Current Consultations

• Notice to Stakeholders - Release of draft Guidance document for consultation: Submission and Information Requirements for Extraordinary Use New Drugs (EUNDS) [2013-02-12]
• Consultation on the new Prescription Drug List [2012-12-24]
• Notice to Stakeholders - Release of draft Guidance document for consultation: Submission Information for Human-Use Biologic Drugs Derived from Plant Molecular Farming (PMF) [2012-12-17]
• Consultation on Health Canada's Public Clinical Trials Database [2012-12-13]
• Notice - DRAFT 2^nd Edition "Guidance Document for Cell, Tissue and Organ Establishments: Safety of Human Cells, Tissues and Organs for Transplantation" for consultation [2012-10-02]

Past Consultations

• Notice to Stakeholders -- Release of the Draft Guidance Interpreting the Blood Regulations for stakeholder consultation [2012-05-28]
• Release of revised guidance document: considerations for inclusion of women in clinical trials and analysis of data by sex [2012-01-09]
• Consultation on proposed Phase II of the Summary Basis of Decision Project [2011-10-19]
• Release of Draft Guidance Document: Regulatory Framework for Allergenic Substances of Biological Origin used for the Diagnosis or Treatment of Allergic Diseases [2011-09-15]
• Draft Guidance Document - Product Monograph - Part III: Consumer Information [2011-07-21]
• Notice - Good Laboratory Practice (GLP) Recognition for Canadian Facilities: Reminder to schedule your inspection before the end of the transition period [2010-09-30]